After a marginal rise in shares and then decline, Taylor Wimpey鈥檚 sale meets with ambiguity from analysts

We all knew Taylor Wimpey was going to sell its North American arm, so when the announcement came last Thursday, its shares didn鈥檛 so much fly of the chart as nudge slightly upwards. But their decline since then in part reflects the ambiguity of analysts towards the selling off of one of the most profitable parts of the housebuilder鈥檚 empire.

鈥淚t鈥檚 punched an enormous hole into profitability,鈥 said Robin Hardy, an analyst at Peel Hunt. The 拢595m sale of the US and Canadian businesses to TMM Holdings, a partnership of US investment funds, robs the company of one of its crown jewels, he said: 鈥淚t鈥檚 selling the [part of the business with the] highest return and the one with the best recovery prospects.鈥 The housebuilder can now pay down most of its 拢654m debt, but the interest payment savings, which he estimates will be about 拢17m-19m a year, are no match for the 拢93.8m in profits the American arm generated last year.

Yet other analysts think Taylor Wimpey will now be able to focus on its UK operation without distractions from over the Atlantic. 鈥淪plitting
the management team between the UK and US meant the business wasn鈥檛 properly focused,鈥 said Rachel Waring, an analyst at Panmure Gordon. 鈥淚 would imagine it will be more aggressive in buying land.鈥 The price was also good one: 鈥淚t鈥檚 a positive move. They have achieved what looks like a very good price鈥, said Waring. Kevin Cammack, an analyst at Cenkos, believes the share price could hit 50p in the next 12-18 months. Its current position is 41p.

Still, there are mutterings from analysts that the banks that are currently bankrolling Taylor Wimpey pressured the firm to sell up in the US. 鈥淚f they hadn鈥檛 sold the US and Canadian business then the debt funding would have run out by 2012,鈥 said one source. The firm is now a simpler one. But one with better returns? Analysts are unsure.

citywatch